April 13, 2023 — LifeQ, a health technology company that uses globally-recognized watch brands to gather personalized, clinical-grade data, announced it will launch the first phase of its virtual care platform at the Health Information Management Systems Society’s (HIMSS 2023) annual conference taking place from April 17-21 at McCormick Place Convention Center in Chicago, IL.
“LifeQ offers a 24/7 lens into the body, generating actionable health insights from personal wearable devices and assisting in screening for disease and illness and uncovering its root cause,” stated Laurie Olivier, LifeQ CEO and co-founder. He added, “We look forward to sharing LifeQ’s offerings and insights with the greater healthcare community at HIMSS and engaging with other distinguished leaders in this space.” He noted LifeQ’s two key value propositions: enabling everyday affordable wearable devices to provide near clinical-grade health information streams; and using this data to generate health and wellness solutions for consumer, business, and clinical applications. The company notes its tools are becoming the preferred health enabler and benchmark for the world’s top consumer electronics companies, empowering their devices to propel the next wave of digitally enabled insurance and health management.
During HIMSS. Dr. Franco du Preez, Chief Scientist at LifeQ, will present a 20-minute talk, Tracking aging with wearable technology: Results from a “Wearabolome-meets-Epigenome” pilot study, on April 18 at 10:45 a.m. His talk will showcase results from a first-of-its-kind study that links lifestyle choices tracked via wearable devices to changes in the epigenomic regulation of DNA, a major driver of aging. Preez will provide an overview of the work the LifeQ team, positioned at the forefront of tracking aging to generate suites of real-time physiological data with its BioAge, a tool that delivers daily personalized health insights. By combining cutting-edge wearable technology with insights from epigenetic research, empowering people to take control of their health and well-being.
Additionally, Olivier will present a Market Debut Session at HIMSS, “The virtual care platform leveraging everyday wearables: A personalized and preventative approach,” on April 19, at at 10:45 a.m. In doing so, Olivier will highlight how everyday affordable consumer wearables may be utilized to delay, flag, and manage chronic disease; and how leveraging systems biology, LifeQ is harvesting a unique suite of wearable biometrics. He will delve into ways the broad-based, personalized, preventative, and real-time virtual care platform can reduce healthcare costs and address the shortfall in a primary care capacity.
Founded in 2010 (incorporated 2014), Apharetta, GA-based LifeQ (HIMSS Booth 7137 – Hall B, North Building, Level 3) is an independent provider of biometrics and health insights derived from wearable devices, trusted by some of the world’s most prominent brands, including Tag Heuer, Louis Vuitton, Hublot, Montblanc, Fossil Group, Samsung, Suunto, Xiaomi, and Motorola.
The statement issued by the company ahead of HIMSS noted the significance of its technology in the following summary: By providing a 24/7 lens into the body, LifeQ offers a holistic view of the way various everyday behaviors and environment influence the health of users, covering a fast-expanding suite of physiological systems of the human body. The generation of highly accurate biometrics for consumers, athletes, and the acutely and chronically ill allows for the earlier detection of health problems, better management of existing problems, and the prevention of disease. Consumers, wearable device companies, insurers and reinsurers, health-tech companies, clinicians, researchers, and analytics companies all benefit from LifeQ’s multiplicity which, the company notes, representing the future of healthcare.
More information: www.lifeq.com
Find more HIMSS23 conference coverage here